BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7507756)

  • 1. Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
    Shpall EJ; Jones RB; Bearman SI; Stemmer SM; Purdy MH; Heimfeld S; Berenson RJ
    Stem Cells; 1993 Oct; 11 Suppl 3():48-9. PubMed ID: 7507756
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cell selection--clinical experience.
    Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
    Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell selection for autologous bone marrow transplantation.
    Okarma TB
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):9-20. PubMed ID: 1377406
    [No Abstract]   [Full Text] [Related]  

  • 5. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
    Cipolone KM; Carter CS; Yu M; Cottler-Fox M
    Prog Clin Biol Res; 1994; 389():667-73. PubMed ID: 7535463
    [No Abstract]   [Full Text] [Related]  

  • 6. Ex vivo expansion of CD34+ hematopoietic progenitors.
    Moore MA; Schneider JG; Shapiro F; Bengala C
    Prog Clin Biol Res; 1994; 389():217-28. PubMed ID: 7535432
    [No Abstract]   [Full Text] [Related]  

  • 7. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation.
    Cottler-Fox M; Cipolone K; Yu M; Berenson R; O'Shaughnessy J; Dunbar C
    Exp Hematol; 1995 Apr; 23(4):320-2. PubMed ID: 7534711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 positive cell selection by immunomagnetic techniques.
    Bigas A; Amill B; Canals C; Tugues D; García J
    Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
    Petsche D; Hami L; Purdy M; Myers S; Hogan C; Messner H; Briddell R; Heimfeld S; Berenson R; Shpall E
    Prog Clin Biol Res; 1994; 389():415-20. PubMed ID: 7535450
    [No Abstract]   [Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
    Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
    Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
    Berenson RJ
    Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
    [No Abstract]   [Full Text] [Related]  

  • 17. CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.
    Winslow JM; Liesveld JL; Ryan DH; Dipersio JF; Abboud CN
    Bone Marrow Transplant; 1994 Aug; 14(2):265-71. PubMed ID: 7527686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
    Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
    Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
    Laughlin MJ; Christiansen NP; Herzig GP; Blumenson L; Bonney D; Stewart CC
    Cytometry; 1996 Dec; 26(4):235-42. PubMed ID: 8979021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.